Annual Information Update
May 12 2009 - 12:37PM
UK Regulatory
TIDMHIK
RNS Number : 1377S
Hikma Pharmaceuticals Plc
12 May 2009
Annual Information Update
LONDON, 12 May 2009. In accordance with Prospectus Rule 5.2, Hikma
Pharmaceuticals PLC ("Hikma" or "the Company")(LSE: HIK) sets out below a
summary of the information which has been published or made available to the
public over the previous 12 months. The information referred to in this Update
was up to date at the time the information was published, but some information
may now be out of date.
Stock Exchange announcements
Announcements made by the Company via RNS, a Regulatory Information Service, may
be viewed and downloaded from the Company's market news section on the London
Stock Exchange website at (www.londonstockexchange.com/marketnews) or from the
press releases page on the Company's website at
(http://www.hikma.com/investorrelations/rns/).The Stock Exchange announcements
made during the defined period are:
+-----------------------+---------------------------------------------------+
| Date of announcement | Headline of announcement |
+-----------------------+---------------------------------------------------+
| 11 May 09 | Director/PDMR Shareholding |
+-----------------------+---------------------------------------------------+
| 11 May 09 | Total Voting Rights |
+-----------------------+---------------------------------------------------+
| 16 Apr 09 | Director/PDMR Shareholding |
+-----------------------+---------------------------------------------------+
| 09 Apr 09 | Annual Financial Report |
+-----------------------+---------------------------------------------------+
| 19 Mar 09 | Director/PDMR Shareholding |
+-----------------------+---------------------------------------------------+
| 18 Mar 09 | Director/PDMR Shareholding |
+-----------------------+---------------------------------------------------+
| 17 Mar 09 | Final Results |
+-----------------------+---------------------------------------------------+
| 26 Jan 09 | Holding(s) in Company |
+-----------------------+---------------------------------------------------+
| 15 Jan 09 | Director/PDMR Shareholding |
+-----------------------+---------------------------------------------------+
| 14 Jan 09 | Trading Statement |
+-----------------------+---------------------------------------------------+
| 02 Jan 09 | Total Voting Rights |
+-----------------------+---------------------------------------------------+
| 03 Dec 08 | Total Voting Rights |
+-----------------------+---------------------------------------------------+
| 25 Nov 08 | Statement re Injectables Presentation |
+-----------------------+---------------------------------------------------+
| 05 Nov 08 | Interim Management Statement |
+-----------------------+---------------------------------------------------+
| 03 Nov 08 | Total Voting Rights |
+-----------------------+---------------------------------------------------+
| 22 Oct 08 | Blocklisting Interim Review |
+-----------------------+---------------------------------------------------+
| 17 Oct 08 | Director/PDMR Shareholding |
+-----------------------+---------------------------------------------------+
| 13 Oct 08 | Director/PDMR Shareholding |
+-----------------------+---------------------------------------------------+
| 03 Oct 08 | Total Voting Rights |
+-----------------------+---------------------------------------------------+
| 15 Sept 08 | Director/PDMR Shareholding |
+-----------------------+---------------------------------------------------+
| 02 Sept 08 | Total Voting Rights |
+-----------------------+---------------------------------------------------+
| 28 Aug 08 | Interim Results |
+-----------------------+---------------------------------------------------+
| 06 Aug 08 | Total Voting Rights |
+-----------------------+---------------------------------------------------+
| 21 Jul 08 | Trading Statement |
+-----------------------+---------------------------------------------------+
| 02 Jul 08 | Total Voting Rights |
+-----------------------+---------------------------------------------------+
| 25 Jun 08 | Director/PDMR Shareholding |
+-----------------------+---------------------------------------------------+
| 25 Jun 08 | Holding(s) in Company |
+-----------------------+---------------------------------------------------+
| 15 May 08 | Results of Annual General Meeting |
+-----------------------+---------------------------------------------------+
| 15 May 08 | AGM and IMS |
+-----------------------+---------------------------------------------------+
| 15 May 08 | TR-1 Notifications of Major Shareholding |
+-----------------------+---------------------------------------------------+
| 12 May 08 | Annual Information Update |
+-----------------------+---------------------------------------------------+
All of the above announcements were also made by the Company via the NasdaqDubai
stock exchange CANDI system. These announcements may be viewed and downloaded
from the NasdaqDubai website (www.candi.nasdaq.com).
Documents filed with the Financial Services Authority
The company has filed the following documents with the Financial Services
Authority ("FSA") over the previous 12 months. These documents are available to
be viewed via the UKLA's Document Viewing Facility at the Financial Services
Authority, 25 the North Colonnade, London, E14 5HS or at the Company's
registered office.
Documents Filed with the Document Viewing Facility
+-------------------------------------+-------------------------------------+
| Date | Document |
+-------------------------------------+-------------------------------------+
| 9 April 2009 | Annual Report and Accounts 2008 |
+-------------------------------------+-------------------------------------+
| 9 April 2009 | Notice of Annual General Meeting |
| | and Proxy Voting Card |
+-------------------------------------+-------------------------------------+
| 15 May 2008 | Articles of Association, Ordinary |
| | and Special Resolutions passed at |
| | the 2008 AGM |
+-------------------------------------+-------------------------------------+
Documents filed with Companies House
The Company submitted filings to Companies House in relation to the Company's
annual return, financial report & accounts, allotments of shares, Articles of
Association, and ordinary and special resolutions passed at the company's 2008
Annual General Meeting. Copies of all these documents may be obtained from
Companies House, Crown Way, Maindy, Cardiff CF14 3UZ or, if you are a registered
user, they may be viewed and downloaded using Companies House Direct at
www.direct.companieshouse.gov.uk.
Copies of all documents can be obtained from the Company at the registered
office, 13 Hanover Square, London, W1S 1HW.
Henry Knowles
Company Secretary
12 May 2009
- ENDS -
Enquiries:
+-----------------------------------------------+----------------+--+----------------+
| | |
+-----------------------------------------------+------------------------------------+
| Hikma Pharmaceuticals plc | +44 20 7399 2760 |
| Henry Knowles, Company Secretary | |
| Susan Ringdal, Investor Relations Director | |
+-----------------------------------------------+------------------------------------+
| Brunswick Group LLP | +44 20 7404 5959 |
| Jon Coles / Justine McIlroy / Alex Tweed | |
| | |
+-----------------------------------------------+------------------------------------+
| | |
+-----------------------------------------------+----------------+--+----------------+
Notes to Editors
About Hikma
Hikma Pharmaceuticals PLC is a fast growing multinational group focused on
developing, manufacturing and marketing a broad range of both branded and
non-branded generic and in-licensed pharmaceutical products. Hikma's operations
are conducted through three businesses: "Branded", "Injectables" and "Generics".
Hikma's operations are based principally in the Middle East and North Africa
("MENA") region, where it is a market leader and sells across 17 countries, the
United States and Europe. In 2008, the Group achieved revenues of $580.7
million (2007 $449 million) and profit attributable to shareholders was $57.1
million (2007 $63 million). For news and other information, please visit
www.hikma.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
AIUQLLFFKEBXBBE
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024
